Encoded Therapeutics Closes $275 Million Series F Financing for Neurological Drug Development

Leila Ahmed North America Legal Chronicle
Tagged:

Wilson Sonsini Goodrich & Rosati has advised Encoded Therapeutics. Encoded Therapeutics, a clinical-stage biotechnology company, has announced the completion of a $275 million Series F financing…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here